« Return to Article Summary

Combined Influence of Insulin Resistance, Overweight/Obesity, and Fatty Liver As Risk Factors for Type 2 Diabetes

Article Options

Go To PubMed Read Full Abstract, Find Related Articles, and more ... PubMed Link
Go To Abstract Diabetes Care - Read Full Abstract, Read Full Text Article, Access Prior Issues ... Publisher Link
Print Article Summary
Related Articles MDlinx Article Summaries on Similar Topics from Clinician-Valued Journals

1 Food consumption and risk of childhood asthma Pediatric Allergy and Immunology, February 24, 2015

2 Effects of vitamin D-fortified low fat yogurt on glycemic status, anthropometric indexes, inflammation, and bone turnover in diabetic postmenopausal women: A randomised controlled clinical trial Clinical Nutrition, March 11, 2015

3 Rates of ischemic stroke during warfarin treatment for atrial fibrillation Stroke, March 25, 2015

4 Comparison of glycemic and metabolic control in youth with type 1 diabetes with and without antipsychotic medication: Analysis from the Nationwide German/Austrian Diabetes Survey (DPV) Diabetes Care, March 19, 2015

5 Protein biomarkers for the prediction of cardiovascular disease in type 2 diabetes Diabetologia - Clinical and Experimental Diabetes and Metabolism, March 6, 2015

6 Effects of sitagliptin on coronary atherosclerosis evaluated using integrated backscatter intravascular ultrasound in patients with type 2 diabetes: rationale and design of the TRUST study Heart and Vessels, March 23, 2015

7 Impact of probiotics in women with gestational diabetes mellitus on metabolic health: A randomized controlled trial American Journal of Obstetrics and Gynecology, February 27, 2015

8 Effect of high-dose vitamin D repletion on glycemic control in African American men with prediabetes and hypovitaminosis D Endocrine Practice, March 16, 2015

9 Risk of microangiopathy in type 2 diabetes mellitus patients with or without chronic hepatitis C: Results of a retrospective long-term controlled cohort study Digestive and Liver Diseases, March 4, 2015

10 Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the rivaroxaban once daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation (ROCKET AF) The Lancet, March 9, 2015